(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202403 | 202303 | % Var | 202403 | 202303 | % Var | 202403 | 202303 | % Var | |
| Sales | 56391.40 | 59482.20 | -5.20 | 202751.70 | 208121.40 | -2.58 | 202751.70 | 208121.40 | -2.58 |
| Other Income | 1188.80 | 1203.00 | -1.18 | 5534.80 | 3292.90 | 68.08 | 5534.80 | 3292.90 | 68.08 |
| PBIDT | 20124.10 | 24809.50 | -18.89 | 60533.70 | 67518.90 | -10.35 | 60533.70 | 67518.90 | -10.35 |
| Interest | 2175.90 | 1614.50 | 34.77 | 7840.80 | 4721.80 | 66.06 | 7840.80 | 4721.80 | 66.06 |
| PBDT | 17948.20 | -6182.90 | -390.29 | 50502.70 | 33419.20 | 51.12 | 50502.70 | 33419.20 | 51.12 |
| Depreciation | 3930.40 | 4119.80 | -4.60 | 16006.20 | 16008.70 | -0.02 | 16006.20 | 16008.70 | -0.02 |
| PBT | 14017.80 | -10302.70 | -236.06 | 34496.50 | 17410.50 | 98.14 | 34496.50 | 17410.50 | 98.14 |
| TAX | 5341.80 | -94.50 | -5752.70 | 5914.70 | 503.30 | 1075.18 | 5914.70 | 503.30 | 1075.18 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 8676.00 | -10208.20 | -184.99 | 28581.80 | 16907.20 | 69.05 | 28581.80 | 16907.20 | 69.05 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 35.69 | 41.71 | -14.44 | 29.86 | 32.44 | -7.97 | 29.86 | 32.44 | -7.97 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1874.00 |
| Dr. Reddys Lab | 1294.85 |
| Cipla | 1322.00 |
| Zydus Lifesciences | 948.00 |
| Lupin | 2277.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: